Filing Details
- Accession Number:
- 0001570562-18-000104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-28 21:29:12
- Reporting Period:
- 2018-08-22
- Accepted Time:
- 2018-08-28 21:29:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1730037 | Kristine Romine | 17901 Von Karman Avenue, Suite 150 Irvine CA 92614 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-22 | 10,000 | $19.83 | 18,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-22 | 160 | $19.98 | 1,360 | No | 4 | A | Indirect | By son |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Indirect | By son |
Footnotes
- The shares were purchased in multiple trades at prices ranging from $19.70 to $19.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose
Billionaire Hedge Funds
